Russell Investments Group
RIGL icon

Russell Investments Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Russell Investments Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97M Buy
76,002
+932
+1% +$28.7K ﹤0.01% 1850
2026
Q1 		$2.02M Buy
75,070
+1,220
+2% +$41K ﹤0.01% 1879
2025
Q4 		$3.16M Sell
73,850
-44,135
-37% -$1.66M ﹤0.01% 1602
2025
Q3 		$3.34M Buy
117,985
+101,528
+617% +$3.04M ﹤0.01% 1564
2025
Q2 		$308K Buy
16,457
+6,746
+69% +$128K ﹤0.01% 2512
2025
Q1 		$175K Buy
9,711
+512
+6% +$10.4K ﹤0.01% 2629
2024
Q4 		$155K Sell
9,199
-1,349
-13% -$25.9K ﹤0.01% 2597
2024
Q3 		$171K Buy
10,548
+124
+1% +$1.46K ﹤0.01% 2549
2024
Q2 		$85.7K Sell
10,424
-1,322
-11% -$13.8K ﹤0.01% 2662
2024
Q1 		$174K Sell
11,746
-2,810
-19% -$37.9K ﹤0.01% 2476
2023
Q4 		$211K Sell
14,556
-4,772
-25% -$48.8K ﹤0.01% 2422
2023
Q3 		$209K Sell
19,328
-1,790
-8% -$21.5K ﹤0.01% 2479
2023
Q2 		$272K Sell
21,118
-40
-0.2% -$541 ﹤0.01% 2407
2023
Q1 		$279K Buy
21,158
+5,589
+36% +$88.8K ﹤0.01% 2410
2022
Q4 		$234K Buy
15,569
+622
+4% +$5.7K ﹤0.01% 2532
2022
Q3 		$175K Buy
14,947
+14,070
+1,604% +$190K ﹤0.01% 2574
2022
Q2 		$9K Sell
877
-8,245
-90% -$166K ﹤0.01% 2848
2022
Q1 		$272K Buy
9,122
+1,165
+15% +$31.5K ﹤0.01% 2394
2021
Q4 		$210K Sell
7,957
-488
-6% -$14.7K ﹤0.01% 2706
2021
Q3 		$305K Hold
8,445
– – ﹤0.01% 2645
2021
Q2 		$365K Sell
8,445
-17,305
-67% -$653K ﹤0.01% 2711
2021
Q1 		$879K Sell
25,750
-34,245
-57% -$1.36M ﹤0.01% 2302
2020
Q4 		$2.1M Sell
59,995
-33,060
-36% -$957K ﹤0.01% 1733
2020
Q3 		$2.23M Buy
93,055
+30,200
+48% +$742K ﹤0.01% 1612
2020
Q2 		$1.15M Buy
62,855
+16,579
+36% +$298K ﹤0.01% 1976
2020
Q1 		$719K Buy
46,276
+42,536
+1,137% +$905K ﹤0.01% 2005
2019
Q4 		$79K Sell
3,740
-6,290
-63% -$130K ﹤0.01% 2934
2019
Q3 		$188K Sell
10,030
-3,746
-27% -$77.4K ﹤0.01% 2630
2019
Q2 		$359K Buy
13,776
+10,686
+346% +$241K ﹤0.01% 2371
2019
Q1 		$80K Buy
+3,090
New +$70.6K ﹤0.01% 2755
2017
Q1 		– Sell
-19,075
Closed -$459K – 3058
2016
Q4 		$459K Buy
+19,075
New +$546K ﹤0.01% 2496

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Russell Investments Group's RIGL Position: Q2 2026 in Review

Russell Investments Group increased its Rigel Pharmaceuticals (RIGL) stake by 1.2% in Q2 2026, buying an estimated $28.7K and bringing the position to 76,002 shares worth $2.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1850.

Russell Investments Group first reported a position in RIGL in Q4 2016 and has held it in 31 quarters since. The position peaked at $3.34M in Q3 2025. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Russell Investments Group held 76,002 shares of Rigel Pharmaceuticals worth $2.97M as of Q2 2026.
  • Russell Investments Group bought 932 Rigel Pharmaceuticals shares in Q2 2026, an estimated $28.7K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1850 holding.
  • Russell Investments Group first reported a position in Rigel Pharmaceuticals in Q4 2016 and has held it in 31 quarters since.
  • Russell Investments Group's Rigel Pharmaceuticals position peaked at $3.34M in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.